CHIP is characterized by the presence of clonal mutations with an allelic frequency >2% in the peripheral blood without dysplasia, overt hematological neoplasms, or abnormalities in blood cell count. This evidence concerns the gene STUB1 and hematopoietic and lymphoid system neoplasm.